
Menssana Research Inc.
- Home
- Companies
- Menssana Research Inc.
- Products
- Heartsbreath - Breath Test for Heart ...

Heartsbreath - Breath Test for Heart Transplant Rejection
The HeartsbreathTM test is a non-invasive breath test for breath biomarkers that predict the probability of grade 3 rejection in heart transplant recipients who received their transplants in the preceding year. It employs a breath collection apparatus (BCA) for collection of volatile organic compounds in breath onto a sorbent trap, as well as for the collection of a separate sample of room air.
Most popular related searches
breath testing
heart transplantation
heart transplant
breath collection
drug administration
drug approval
biomarker
clinical testing
Analysis of the organic compounds in breath and room air is performed by gas chromatography and mass spectroscopy, which are laboratory tests.
The Food & Drug Administration approved the Heartsbreath test for clinical use as a Humanitarian Device exemption.